2 drug(s) with this reaction
1,519 total reports
Cytokine Release Syndrome has been reported as an adverse reaction across 2 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,519 adverse event reports mention cytokine release syndrome in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with cytokine release syndrome, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have cytokine release syndrome listed in their FDA adverse event reports, sorted by report count:
In addition to cytokine release syndrome, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
2 drug(s) manufactured by Amgen Inc have cytokine release syndrome listed in their FDA adverse event reports: BLINATUMOMAB, FILGRASTIM.
There are a combined 1,519 reports of cytokine release syndrome across 2 Amgen Inc drug(s) in the FDA adverse event database.